Literature DB >> 8014518

Norwalk virus infection of volunteers: new insights based on improved assays.

D Y Graham1, X Jiang, T Tanaka, A R Opekun, H P Madore, M K Estes.   

Abstract

Norwalk virus infection is a common cause of gastroenteritis in humans. The clinical features and virologic and immunologic responses following oral administration of Norwalk virus to 50 volunteers were monitored. New ELISAs using recombinant virus particles as the antigen source were used to assess the pattern of virus shedding and the specific immune responses. Forty-one subjects (82%) became infected; 68% were symptomatic and 32% were asymptomatic. The proportion of subjects infected was similar for those with and without preexisting antibody (82% vs. 60%; P > .2). The magnitude of seroconversion was highest in subjects who had vomiting. The peak of viral shedding was between 25 and 72 h, and virus first appeared in stool at 15 h. Specimens collected 7 days after inoculation remained positive. These results show a higher infection rate, more subclinical infections, and longer virus excretion following Norwalk virus inoculation than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014518     DOI: 10.1093/infdis/170.1.34

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  132 in total

1.  Identification of an epitope common to genogroup 1 "norwalk-like viruses".

Authors:  A D Hale; T N Tanaka; N Kitamoto; M Ciarlet; X Jiang; N Takeda; D W Brown; M K Estes
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup I Norwalk-like viruses.

Authors:  S Kobayashi; K Sakae; Y Suzuki; K Shinozaki; M Okada; H Ishiko; K Kamata; K Suzuki; K Natori; T Miyamura; N Takeda
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

3.  Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens.

Authors:  Anne M Hutson; Robert L Atmar; Donald M Marcus; Mary K Estes
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Asymptomatic and symptomatic excretion of noroviruses during a hospital outbreak of gastroenteritis.

Authors:  Chris I Gallimore; David Cubitt; Nelita du Plessis; Jim J Gray
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

5.  Detection of enteric viruses in shellfish from the Norwegian coast.

Authors:  M Myrmel; E M M Berg; E Rimstad; B Grinde
Journal:  Appl Environ Microbiol       Date:  2004-05       Impact factor: 4.792

6.  Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle.

Authors:  Grant S Hansman; David W Taylor; Jason S McLellan; Thomas J Smith; Ivelin Georgiev; Jeremy R H Tame; Sam-Yong Park; Makoto Yamazaki; Fumio Gondaira; Motohiro Miki; Kazuhiko Katayama; Kazuyoshi Murata; Peter D Kwong
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

7.  Genogroup I and II noroviruses detected in stool samples by real-time reverse transcription-PCR using highly degenerate universal primers.

Authors:  Gary P Richards; Michael A Watson; Rebecca L Fankhauser; Stephan S Monroe
Journal:  Appl Environ Microbiol       Date:  2004-12       Impact factor: 4.792

8.  Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication.

Authors:  Larissa B Thackray; Erning Duan; Helen M Lazear; Amal Kambal; Robert D Schreiber; Michael S Diamond; Herbert W Virgin
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

9.  Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus.

Authors:  Nadim J Ajami; Meagan A Barry; Berenice Carrillo; Zana Muhaxhiri; Frederick H Neill; B V Venkataram Prasad; Antone R Opekun; Mark A Gilger; David Y Graham; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

10.  Herd immunity to GII.4 noroviruses is supported by outbreak patient sera.

Authors:  Jennifer L Cannon; Lisa C Lindesmith; Eric F Donaldson; Lauryn Saxe; Ralph S Baric; Jan Vinjé
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.